Congratulations to Dr. Pushkal Garg on his appointment as EVP, Chief Research & Development Officer at Alnylam Pharmaceuticals. 

Written By Kimberly Hicks
Kimberly Hicks
Previous

Apellis Pharmaceuticals receives FDA approval of EMPAVELI® (pegcetacoplan)
Next

Meeting the Moment: Supporting Biotech Hiring in a Surplus Market